GA101, a Novel Humanized Type II CD20 Antibody with Glycoengineered Fc and Enhanced Cell Death Induction, Mediates Superior Efficacy in a Variety of NHL Xenograft Models in Comparison to Rituximab.

抗体依赖性细胞介导的细胞毒性 套细胞淋巴瘤 淋巴瘤 抗体 美罗华 癌症研究 体内 CD20 免疫学 医学 单克隆抗体 生物 生物技术
作者
Thomas Friess,Christian Gerdes,Adam Nopora,Monika Patre,Susanne Preiß,Erwin van Puijenbroek,Christine Schuell,Sabine Bauer,Pablo Umaña,Christian Klein
出处
期刊:Blood [Elsevier BV]
卷期号:110 (11): 2338-2338 被引量:10
标识
DOI:10.1182/blood.v110.11.2338.2338
摘要

Abstract GA101 is a novel humanized and glycoengineered CD20 antibody that was derived by humanization of the parental B-Ly1 mouse antibody and subsequent glycoengineering leading to the following characteristics: high affinity binding to the CD20 type II epitope; low complement dependent cytotoxicity (CDC) activity; high direct cell death induction; and high antibody-dependent cellular cytotoxicity (ADCC) potency. In vivo studies examined the consequences of GA101 on the growth of aggressive NHL xenograft models in SCID beige mice and the subsequent effects on survival. These studies demonstrated an outstanding dose-dependent anti-tumor activity of GA101. In particular, GA101 mediated superior anti-tumor efficacy in staged s.c. Z138 mantle cell lymphoma (MCL) and SU-DHL4 diffuse large B cell lymphoma (DLBCL) xenograft models in direct comparison to rituximab. Weekly dosing of GA101 at 10 mg/kg (Z138 model) or 30 mg/kg (SU-DHL4) was able to induce complete tumor remission and long-term survival (cures) in all animals. Consistent anti-tumor efficacy against established tumors was also observed in a number of additional NHL models including Raji Burkitt’s lymphoma or OCI-LY18 DLBCL models. In addition GA101 was evaluated in an orthotopic disseminated Z138 model. After i.v. injection of Z138 cells SCID beige mice developed large intraperitoneal lymphoid tumors in the ovary. Several experiments showed that GA101 mediated increased overall and median survival in this model in direct comparison to rituximab. All xenograft studies were performed in SCID beige mice that are incompetent for NK-mediated ADCC. Indeed, control experiments with non-glycoengineered GA101 in s.c. xenograft models suggest that the superiority of GA101 does not depend on enhanced interactions of the engineered Fc region with murine effector cells such as macrophages/monocytes or granulocytes. Thus, the anti-tumor effects of GA101 in s.c. xenograft models can be primarily attributed to non-effector cell mediated activities. Currently, experiments are ongoing to evaluate the efficacy of GA101 in combination with classical chemotherapy regimens and novel targeted agents. First results from these studies will be presented during the 2007 ASH Annual Meeting. In summary it can be assumed that the combination of the recognition of a type II epitope together with improved ADCC potency might translate into superior efficacy in the clinical treatment of CD20 positive malignant diseases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
杜欣悦发布了新的文献求助10
刚刚
刚刚
多看点文献吧完成签到,获得积分10
刚刚
思源的应助被nxdr采纳,获得10
1秒前
冯梦梦完成签到,获得积分10
2秒前
之子之远完成签到,获得积分10
2秒前
传奇3的应助被MADAO采纳,获得30
4秒前
大白完成签到 ,获得积分10
4秒前
CITY111119发布了新的文献求助10
4秒前
4秒前
4秒前
zww113发布了新的文献求助10
4秒前
5秒前
冯梦梦发布了新的文献求助10
5秒前
童童完成签到,获得积分10
6秒前
6秒前
7ian完成签到 ,获得积分10
7秒前
欢喜夏天完成签到,获得积分10
7秒前
清辉影的应助被漫漫采纳,获得10
8秒前
9秒前
等风归发布了新的文献求助10
10秒前
11秒前
昏睡的绿海完成签到,获得积分10
11秒前
AKKK完成签到 ,获得积分10
11秒前
11秒前
逆流沙完成签到,获得积分10
12秒前
FashionBoy的应助被马亚斌采纳,获得10
12秒前
839788336完成签到,获得积分10
13秒前
归帆发布了新的文献求助10
13秒前
iNk的应助被ladywerwer采纳,获得10
14秒前
NUS完成签到,获得积分10
14秒前
gentle发布了新的文献求助10
14秒前
wspqbs关注了科研通微信公众号
15秒前
xiang完成签到,获得积分10
16秒前
erlangenbio完成签到,获得积分10
16秒前
16秒前
深情安青的应助被杜欣悦采纳,获得10
17秒前
18秒前
modoun完成签到,获得积分10
19秒前
iNk的应助被ladywerwer采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621